Computer Aided Detection Market: Global Analysis and Forecast (2024-2030)

The Computer Aided Detection Market size was valued at USD 836.5 Million in 2023 and the total Computer Aided Detection revenue is expected to grow at a CAGR of 5.78% from 2024 to 2030, reaching nearly USD 1239.63 Million by 2030.

Computer Aided Detection Market Overview:

Computer Aided Detection (CAD) software employs pattern recognition algorithms to assist physicians in interpreting medical images, especially with the increasing volume of diagnostic imaging data. This surge in data elevates the risk of missed abnormalities, driving the demand for CAD systems. Market dynamics are influenced by rising cancer rates and heightened health awareness, particularly in fields like radiology, oncology, and cardiology. However, the high cost of CAD systems poses a barrier to market growth. Despite challenges, technological advancements, expanding applications beyond radiology, and increasing tobacco-related cancer cases drive the growth of the computer aided detection market, especially in regions like North America and Asia Pacific. Computer Aided Detection MarketTo know about the Research Methodology :- Request Free Sample Report

Computer Aided Detection Market Dynamics

The computer-aided detection market is propelled by rising cancer rates and heightened health awareness. The computer aided detection market is intensely influenced by two primary factors: the increasing prevalence of cancer and the growing awareness among the populace regarding the importance of regular health check-ups. As cancer-related fatalities continue to escalate, governments worldwide are initiating various awareness campaigns, complemented by concerted efforts from key industry stakeholders to develop cutting-edge imaging technologies. For instance, data from the American Cancer Society (ACS) highlights the severity of the issue, revealing that in 2022 alone, an estimated 43,250 women succumbed to breast cancer, while 287,850 new cases of invasive breast cancer emerged. Particularly striking is the statistic indicating that women aged 50 and above accounted for a staggering 83% of new instances of invasive breast cancer and 91% of all breast cancer-related deaths. Within this landscape, Computer Aided Detection (CAD) plays a pivotal role, as its applications in cancer detection and treatment serve as a driving force propelling the growth of the computer aided detection market. The increasing utilization of Computer-Aided Detection (CAD) systems in the medical domain is a notable trend. The computer aided detection market is witnessing growth and evolution driven by the expanding implementation of CAD systems across diverse medical disciplines. Initially employed primarily in radiology for discerning complexities in images like mammograms, CAD systems have swiftly permeated numerous other medical specialties. Their increasing utilization in fields beyond radiology, including pathology, cardiology, oncology, and neurology, underscores their adaptability and efficacy in supporting medical professionals across various domains. CAD's ability to enable early identification, precise diagnosis, and treatment planning for a multitude of illnesses is revolutionizing healthcare practices. The escalating adoption and integration of CAD systems across a spectrum of medical specialties underscore their transformative impact on healthcare delivery. Their proliferation in diverse specializations reflects their potential to facilitate earlier and more accurate diagnoses, enhance treatment outcomes, and elevate patient care standards. Consequently, the rising application of CAD systems in the medical field is a key driver fueling market growth within the computer aided detection market. The high cost of (CAD) systems poses a formidable barrier that threatens to impede the growth trajectory of the computer aided detection market. Many healthcare facilities face obstacles in integrating CAD systems into their diagnostic workflows due to the significant initial investment required for acquisition and implementation. CAD systems typically necessitate specialized medical imaging hardware and software, resulting in substantial upfront costs, particularly for smaller healthcare facilities or those operating on tighter budgets. The total cost of ownership encompasses ongoing expenses for maintenance, updates, and licensing beyond the initial investment. Ensuring the system remains up-to-date with advancements and compliant with regulatory requirements further amplifies the overall cost. Additionally, training healthcare staff to efficiently utilize CAD systems and seamlessly integrate them into existing operations demands additional time and resources. The expenses associated with both initial deployment training and ongoing instruction for new features or updates contribute to the financial burden. The high cost of CAD systems has instilled hesitancy among healthcare providers, especially smaller practices or institutions with limited financial resources, to embrace these technologies. This reluctance curtails patients' access to the benefits of CAD systems, which offer more precise and effective diagnoses. Moreover, the cumulative effect of maintenance expenses strains the financial resources of healthcare institutions, particularly smaller practices or those with limited resources. Thus, the computer aided detection market growth is curtailed by their high cost. The advancements in technology linked with Computer-Aided Detection (CAD) are on the rise. Technological advancements stand as the primary catalyst propelling the growth and expansion of the computer aided detection market within the healthcare sector. These advancements continually enhance CAD systems, boosting their adaptability, precision, and diagnostic capabilities across a broad spectrum of medical disorders. Key developments such as deep learning algorithms, machine learning, and artificial intelligence (AI) play pivotal roles in advancing CAD systems. They enable CAD software to efficiently process vast volumes of medical imaging data with unprecedented speed and accuracy, leading to more reliable and precise anomaly detection in MRIs, CT scans, X-rays, and other imaging modalities. As technological advancements persist, CAD systems are poised to further improve in detection capabilities, adaptability, and integration with healthcare ecosystems. The relentless pursuit of technology enhancements within the CAD industry fuels market growth, offering immense potential to revolutionize patient care, elevate diagnostic capabilities, and shape the trajectory of healthcare delivery. Thus, the ongoing surge in technological advancements serves as a driving force behind the expansion of the computer aided detection market. The surge in smoking-related cancer cases propel the computer aided detection market. Over the past two decades, the field of diagnostic cancer imaging, particularly within the computer aided detection market, has undergone remarkable evolution, significantly impacting cancer research and clinical management. Notably, tobacco smoking stands out as one of the most prevalent causes of lung cancer, ranking as a leading cause of mortality in the U.S. Furthermore, forecasts suggest a rapid increase in smoking-related deaths among women during the forecast period. As per the American Cancer Society (ACS), cancer accounts for one in five deaths in the U.S., with smoking responsible for 30% of all cancer-related fatalities and 20% of diagnosed cases. Meanwhile, global statistics from the World Health Organization (WHO) estimate that cancer was the leading cause of death worldwide in 2022, resulting in approximately 10 million deaths, or nearly one in six deaths. The intensified governmental efforts to promote cancer awareness and treatment are expected to accelerate the growth of the computer aided detection market. Notably, initiatives like the relaunch of the Cancer Moonshot by the U.S. government in February 2022 aim to reduce the cancer mortality rate by at least 50% over the next 25 years. A significant trend within the computer aided detection market is the increasing utilization of AI and machine learning algorithms in CAD systems. These advancements have significantly enhanced the accuracy and efficiency of anomaly detection, thereby improving diagnostic capabilities while reducing false-positive rates. For instance, in 2020, Olympus Corporation introduced the cutting-edge ENDO-AID CAD endoscopic program, driven by artificial intelligence (AI), specifically designed for colon screenings. This platform provides real-time presentations of automatically detected problematic lesions, revolutionizing colon cancer detection. Another notable development is the expansion of CAD into various medical specialties beyond radiology. While CAD systems were initially focused on mammography for early breast cancer detection, they have now diversified into fields such as gastrointestinal, cardiovascular, and lung imaging. This expansion has broadened the applications of CAD by enabling the detection of various diseases and conditions across multiple medical disciplines, further driving the growth of the computer aided detection market. Tobacco-related cancer incidence rates & case numbers for countries with the top highest male tobacco- smoking prevalence worldwide
Country Male Smoking Prevalence Tobacco-related Cancer Incidence Rates (per 100,000) Tobacco-related Cancer Incident Cases (2012) Tobacco-related Cancer Incident Cases (2030 Projection) % Change from 2012 to 2030
Greece 63 70.0 18,387 22,678 23.3%
Albania 60.1 85.4 3,536 5,461 54.4%
Russian Federation 59.4 82.3 188,969 205,554 8.8%
Papua New Guinea 57.7 65.6 2,739 4,881 78.2%
Indonesia 61.3 50.1 109,996 186,908 69.9%
Georgia 56.6 55.2 4,002 4,465 11.6%
Tunisia 52.7 46.3 5,053 9,007 78.3%
Armenia 50.9 103.4 4,584 5,854 27.7%
China 50.4 113.1 2,010,520 3,421,773 70.2%

Computer Aided Detection Market Segment Analysis

Based on application, the computer aided detection market is segmented by Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, Others. In 2023, the breast cancer segment took the lead in market dominance, capturing a substantial share of XX%. This was propelled by the escalating global incidence of breast cancer, coupled with heightened awareness, proactive initiatives, early detection methods, and advancements in treatment modalities. In 2020, breast cancer diagnoses reached 2.3 million among women, resulting in 685,000 fatalities worldwide. Meanwhile, the lung cancer segment is poised to emerge as the fastest-growing segment, projected to achieve a remarkable CAGR of XX% during the forecast period spanning from 2023 to 2030. According to the National Cancer Institute (NCI), lung cancer stood out in 2021 as the leading cause of both cancer cases and fatalities globally. With an estimated 2 million new cases and 1.8 million deaths attributed to lung cancer, it ranks as the second most commonly diagnosed cancer among both genders, following prostate cancer in men and breast cancer in women. The surge in lung cancer prevalence is attributed to increased accessibility to tobacco and heightened industrialization in developing nations. Computer Aided Detection Market

Computer Aided Detection Market Regional Analysis:

In 2023, North America took the lead in the computer aided detection market, capturing the largest revenue share at XX%. The widespread adoption of CAD for cancer diagnosis, coupled with increased healthcare spending in the region, is poised to drive computer aided detection market expansion. According to the American Cancer Society, cancer ranks as the second leading cause of death in the U.S. after heart disease, with 602,350 reported deaths attributed to cancer in 2020, affecting 284,619 females and 317,731 males. Asia Pacific is expected to witness the fastest compound annual growth rate (CAGR) of 7.4% during the forecast period. The region's high prevalence of cancer-related mortality is a significant driver for the demand for computer-aided cancer detection and diagnosis. A study published in the National Library of Medicine revealed that the cancer incidence rate in Asia stood at 169.1 per 100,000 individuals, accounting for 49.3% of global cancer cases. Notably, breast (10.8%), lung (13.8%), and colorectal (10.6%) cancers were identified as the most common types.

Computer Aided Detection Market Scope: Inquire before buying

Global Computer Aided Detection Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 836.5 Mn.
Forecast Period 2024 to 2030 CAGR: 5.78% Market Size in 2030: US $ 1239.63 Mn.
Segments Covered: by Imaging Modalities Mammography Magnetic Resonance Imaging Ultrasound Imaging Tomosynthesis Nuclear Imaging Others
by Application Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Liver Cancer Bone Cancer Others
by End-user Hospitals Diagnostic Centers Research Centers

Computer Aided Detection Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Computer Aided Detection Market Key Players:

Computer Aided Detection Manufacturers in North America: 1. Hologic, Inc. (USA) 2. iCAD, Inc. (Nashua, New Hampshire, USA) 3. EDDA Technology, Inc. (Cary, North Carolina, USA) 4. Fujifilm Medical Systems USA, Inc. (Itasca, Illinois, USA) 5. Invivo Corporation (Alachua, Florida, USA) 6. GE Healthcare (Chicago, Illinois, USA) 7. Philips Healthcare (Amsterdam, Netherlands) 8. EDDA Technology, Inc. (Cary, North Carolina, USA) 9. Hologic Inc. (Marlborough, Massachusetts, USA) 10. IBM Corporation (Armonk, New York, USA) 11. Riverain Technologies LLC. (Lexington, Massachusetts, USA) 12. McKesson Corporation (Irving, Texas, USA) Computer Aided Detection Manufacturers in Europe: 13. Siemens Healthineers (Erlangen, Germany) 14. Agfa-Gevaert N.V. (Mortsel, Belgium) 15. Vucomp (Oslo, Norway) 16. Siemens Healthcare (Erlangen, Germany) 17. Median Technologies (Sophia Antipolis, France) 18. Koninklijke Philips N.V. (Amsterdam, Netherlands) Computer Aided Detection Manufacturers in Asia-Pacific: 19. Toshiba Medical Systems Corporation (Tōkyō, Japan) 20. Hitachi Medical Corporation (Tokyo, Japan) 21. CANON MEDICAL SYSTEMS CORPORATION (Otawara, Japan) FAQs: 1. Which region has the largest share in Global Computer Aided Detection Market? Ans: North America region holds the highest share in 2023. 2. What is the growth rate of Global Computer Aided Detection Market? Ans: The Global Computer Aided Detection Market is growing at a CAGR of 5.78% during forecasting period 2024-2030. 3. What segments are covered in Global Computer Aided Detection market? Ans: Global Computer Aided Detection Market is segmented into Imaging Modalities, Application, End-User and region. 4. Who are the key players in Global Computer Aided Detection market? Ans: The important key players in the Global Computer Aided Detection Market are – Hologic, Inc. (USA), iCAD, Inc. (Nashua, New Hampshire, USA), EDDA Technology, Inc. (Cary, North Carolina, USA), Fujifilm Medical Systems USA, Inc. (Itasca, Illinois, USA), Invivo Corporation (Alachua, Florida, USA), GE Healthcare (Chicago, Illinois, USA), Philips Healthcare (Amsterdam, Netherlands), EDDA Technology, Inc. (Cary, North Carolina, USA). 5. What is the study period of this market? Ans: The Global Computer Aided Detection Market is studied from 2023 to 2030.
1. Computer Aided Detection Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Computer Aided Detection Market: Dynamics 2.1. Computer Aided Detection Market Trends by Region 2.1.1. North America Computer Aided Detection Market Trends 2.1.2. Europe Computer Aided Detection Market Trends 2.1.3. Asia Pacific Computer Aided Detection Market Trends 2.1.4. Middle East and Africa Computer Aided Detection Market Trends 2.1.5. South America Computer Aided Detection Market Trends 2.2. Computer Aided Detection Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Computer Aided Detection Market Drivers 2.2.1.2. North America Computer Aided Detection Market Restraints 2.2.1.3. North America Computer Aided Detection Market Opportunities 2.2.1.4. North America Computer Aided Detection Market Challenges 2.2.2. Europe 2.2.2.1. Europe Computer Aided Detection Market Drivers 2.2.2.2. Europe Computer Aided Detection Market Restraints 2.2.2.3. Europe Computer Aided Detection Market Opportunities 2.2.2.4. Europe Computer Aided Detection Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Computer Aided Detection Market Drivers 2.2.3.2. Asia Pacific Computer Aided Detection Market Restraints 2.2.3.3. Asia Pacific Computer Aided Detection Market Opportunities 2.2.3.4. Asia Pacific Computer Aided Detection Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Computer Aided Detection Market Drivers 2.2.4.2. Middle East and Africa Computer Aided Detection Market Restraints 2.2.4.3. Middle East and Africa Computer Aided Detection Market Opportunities 2.2.4.4. Middle East and Africa Computer Aided Detection Market Challenges 2.2.5. South America 2.2.5.1. South America Computer Aided Detection Market Drivers 2.2.5.2. South America Computer Aided Detection Market Restraints 2.2.5.3. South America Computer Aided Detection Market Opportunities 2.2.5.4. South America Computer Aided Detection Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Computer Aided Detection Industry 2.8. Analysis of Government Schemes and Initiatives For Computer Aided Detection Industry 2.9. Computer Aided Detection Market Trade Analysis 2.10. The Global Pandemic Impact on Computer Aided Detection Market 3. Computer Aided Detection Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 3.1.1. Mammography 3.1.2. Magnetic Resonance Imaging 3.1.3. Ultrasound Imaging 3.1.4. Tomosynthesis 3.1.5. Nuclear Imaging 3.1.6. Others 3.2. Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 3.2.1. Breast Cancer 3.2.2. Lung Cancer 3.2.3. Colorectal Cancer 3.2.4. Prostate Cancer 3.2.5. Liver Cancer 3.2.6. Bone Cancer 3.2.7. Others 3.3. Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 3.3.1. Hospitals 3.3.2. Diagnostic Centers 3.3.3. Research Centers 3.4. Computer Aided Detection Market Size and Forecast, by Region (2023-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Computer Aided Detection Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 4.1.1. Mammography 4.1.2. Magnetic Resonance Imaging 4.1.3. Ultrasound Imaging 4.1.4. Tomosynthesis 4.1.5. Nuclear Imaging 4.1.6. Others 4.2. North America Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 4.2.1. Breast Cancer 4.2.2. Lung Cancer 4.2.3. Colorectal Cancer 4.2.4. Prostate Cancer 4.2.5. Liver Cancer 4.2.6. Bone Cancer 4.2.7. Others 4.3. North America Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 4.3.1. Hospitals 4.3.2. Diagnostic Centers 4.3.3. Research Centers 4.4. North America Computer Aided Detection Market Size and Forecast, by Country (2023-2030) 4.4.1. United States 4.4.1.1. United States Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 4.4.1.1.1. Mammography 4.4.1.1.2. Magnetic Resonance Imaging 4.4.1.1.3. Ultrasound Imaging 4.4.1.1.4. Tomosynthesis 4.4.1.1.5. Nuclear Imaging 4.4.1.1.6. Others 4.4.1.2. United States Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 4.4.1.2.1. Breast Cancer 4.4.1.2.2. Lung Cancer 4.4.1.2.3. Colorectal Cancer 4.4.1.2.4. Prostate Cancer 4.4.1.2.5. Liver Cancer 4.4.1.2.6. Bone Cancer 4.4.1.2.7. Others 4.4.1.3. United States Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 4.4.1.3.1. Hospitals 4.4.1.3.2. Diagnostic Centers 4.4.1.3.3. Research Centers 4.4.2. Canada 4.4.2.1. Canada Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 4.4.2.1.1. Mammography 4.4.2.1.2. Magnetic Resonance Imaging 4.4.2.1.3. Ultrasound Imaging 4.4.2.1.4. Tomosynthesis 4.4.2.1.5. Nuclear Imaging 4.4.2.1.6. Others 4.4.2.2. Canada Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 4.4.2.2.1. Breast Cancer 4.4.2.2.2. Lung Cancer 4.4.2.2.3. Colorectal Cancer 4.4.2.2.4. Prostate Cancer 4.4.2.2.5. Liver Cancer 4.4.2.2.6. Bone Cancer 4.4.2.2.7. Others 4.4.2.3. Canada Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 4.4.2.3.1. Hospitals 4.4.2.3.2. Diagnostic Centers 4.4.2.3.3. Research Centers 4.4.3. Mexico 4.4.3.1. Mexico Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 4.4.3.1.1. Mammography 4.4.3.1.2. Magnetic Resonance Imaging 4.4.3.1.3. Ultrasound Imaging 4.4.3.1.4. Tomosynthesis 4.4.3.1.5. Nuclear Imaging 4.4.3.1.6. Others 4.4.3.2. Mexico Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 4.4.3.2.1. Breast Cancer 4.4.3.2.2. Lung Cancer 4.4.3.2.3. Colorectal Cancer 4.4.3.2.4. Prostate Cancer 4.4.3.2.5. Liver Cancer 4.4.3.2.6. Bone Cancer 4.4.3.2.7. Others 4.4.3.3. Mexico Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 4.4.3.3.1. Hospitals 4.4.3.3.2. Diagnostic Centers 4.4.3.3.3. Research Centers 5. Europe Computer Aided Detection Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.2. Europe Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.3. Europe Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 5.4. Europe Computer Aided Detection Market Size and Forecast, by Country (2023-2030) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.4.1.2. United Kingdom Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.4.1.3. United Kingdom Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 5.4.2. France 5.4.2.1. France Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.4.2.2. France Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.4.2.3. France Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 5.4.3. Germany 5.4.3.1. Germany Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.4.3.2. Germany Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.4.3.3. Germany Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 5.4.4. Italy 5.4.4.1. Italy Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.4.4.2. Italy Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.4.4.3. Italy Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 5.4.5. Spain 5.4.5.1. Spain Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.4.5.2. Spain Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.4.5.3. Spain Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 5.4.6. Sweden 5.4.6.1. Sweden Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.4.6.2. Sweden Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.4.6.3. Sweden Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 5.4.7. Austria 5.4.7.1. Austria Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.4.7.2. Austria Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.4.7.3. Austria Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 5.4.8.2. Rest of Europe Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 5.4.8.3. Rest of Europe Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6. Asia Pacific Computer Aided Detection Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.2. Asia Pacific Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.3. Asia Pacific Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4. Asia Pacific Computer Aided Detection Market Size and Forecast, by Country (2023-2030) 6.4.1. China 6.4.1.1. China Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.1.2. China Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.1.3. China Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.2. S Korea 6.4.2.1. S Korea Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.2.2. S Korea Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.2.3. S Korea Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.3. Japan 6.4.3.1. Japan Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.3.2. Japan Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.3.3. Japan Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.4. India 6.4.4.1. India Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.4.2. India Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.4.3. India Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.5. Australia 6.4.5.1. Australia Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.5.2. Australia Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.5.3. Australia Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.6. Indonesia 6.4.6.1. Indonesia Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.6.2. Indonesia Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.6.3. Indonesia Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.7. Malaysia 6.4.7.1. Malaysia Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.7.2. Malaysia Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.7.3. Malaysia Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.8. Vietnam 6.4.8.1. Vietnam Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.8.2. Vietnam Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.8.3. Vietnam Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.9. Taiwan 6.4.9.1. Taiwan Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.9.2. Taiwan Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.9.3. Taiwan Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 6.4.10.2. Rest of Asia Pacific Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 6.4.10.3. Rest of Asia Pacific Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 7. Middle East and Africa Computer Aided Detection Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 7.2. Middle East and Africa Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 7.3. Middle East and Africa Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 7.4. Middle East and Africa Computer Aided Detection Market Size and Forecast, by Country (2023-2030) 7.4.1. South Africa 7.4.1.1. South Africa Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 7.4.1.2. South Africa Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 7.4.1.3. South Africa Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 7.4.2. GCC 7.4.2.1. GCC Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 7.4.2.2. GCC Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 7.4.2.3. GCC Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 7.4.3. Nigeria 7.4.3.1. Nigeria Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 7.4.3.2. Nigeria Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 7.4.3.3. Nigeria Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 7.4.4.2. Rest of ME&A Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 7.4.4.3. Rest of ME&A Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 8. South America Computer Aided Detection Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 8.2. South America Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 8.3. South America Computer Aided Detection Market Size and Forecast, by End User(2023-2030) 8.4. South America Computer Aided Detection Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 8.4.1.2. Brazil Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 8.4.1.3. Brazil Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 8.4.2.2. Argentina Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 8.4.2.3. Argentina Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Computer Aided Detection Market Size and Forecast, by Imaging Modalities (2023-2030) 8.4.3.2. Rest Of South America Computer Aided Detection Market Size and Forecast, by Application (2023-2030) 8.4.3.3. Rest Of South America Computer Aided Detection Market Size and Forecast, by End User (2023-2030) 9. Global Computer Aided Detection Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Computer Aided Detection Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Hologic, Inc. (USA) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. iCAD, Inc. (Nashua, New Hampshire, USA) 10.3. EDDA Technology, Inc. (Cary, North Carolina, USA) 10.4. Fujifilm Medical Systems USA, Inc. (Itasca, Illinois, USA) 10.5. Invivo Corporation (Alachua, Florida, USA) 10.6. GE Healthcare (Chicago, Illinois, USA) 10.7. Philips Healthcare (Amsterdam, Netherlands) 10.8. EDDA Technology, Inc. (Cary, North Carolina, USA) 10.9. Hologic Inc. (Marlborough, Massachusetts, USA) 10.10. IBM Corporation (Armonk, New York, USA) 10.11. Riverain Technologies LLC. (Lexington, Massachusetts, USA) 10.12. McKesson Corporation (Irving, Texas, USA) 10.13. Siemens Healthineers (Erlangen, Germany) 10.14. Agfa-Gevaert N.V. (Mortsel, Belgium) 10.15. Vucomp (Oslo, Norway) 10.16. Siemens Healthcare (Erlangen, Germany) 10.17. Median Technologies (Sophia Antipolis, France) 10.18. Koninklijke Philips N.V. (Amsterdam, Netherlands) 10.19. Toshiba Medical Systems Corporation (Tōkyō, Japan) 10.20. Hitachi Medical Corporation (Tokyo, Japan) 10.21. CANON MEDICAL SYSTEMS CORPORATION (Otawara, Japan) 11. Key Findings 12. Industry Recommendations 13. Computer Aided Detection Market: Research Methodology 14. Terms and Glossary
  • INQUIRE BEFORE BUYING